The development of therapeutic products balances benefits
and adverse consequences, so research quality is required for
the development of the new therapeutic. Astute use of research
quality earlier can add to the value of intellectual property
(IP), especially when the IP is subject to quality assurance due
diligence (QADD). Andrew King, Quality Assurance Manager
for Q-Pharm, aims to explore the reasons for a lab to apply
research quality to improve their science, its reliability and
productivity, and to consider how to begin to apply research
quality.